Sign in
4/A

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-16-091750

Options or other derivatives

  • SVP & Chief Accounting Officer acquired 41,250 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Thomsen Jillian B. · SVP & Chief Accounting Officer

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2015-12-15 Grant or award : show line 1 in the form Restricted Stock Unit +22,500 2023-12-14 22,500 22,500 D
2015-12-15 Grant or award : show line 2 in the form Stock Option +18,750 $15.55 2023-12-14 18,750 18,750 D
Loading xslF345X03/doc4a.xml…